research use only
Cat.No.S5150
|
In vitro |
4-Methylpyridine : 28 mg/mL
DMSO
: Insoluble
Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | Formula | Storage (From the date of receipt) | |||
|---|---|---|---|---|---|
| CAS No. | 949109-75-5 | Download SDF | Storage of Stock Solutions |
|
|
Read more about storage stability stock solution CAS number
| In vitro |
Plant sterols or phytosterols are structurally similar to cholesterol and exist in several forms in plants, including β-sitosterol, campesterol, stigmasterol and cycloartenol. This compound can protect cells from damage by reactive oxygen species. It can promote cell apoptosis. The incorporation of this chemical into lipid rafts, altering their structure, may result in beneficial changes in signal transduction.
|
|---|---|
| In vivo |
Phytosterol and stanol (or phytosterols) consumption reduces intestinal cholesterol absorption, leading to decreased blood LDL-cholesterol levels and lowered cardiovascular disease risk. Recent studies suggest that this compound inhibits the production of carcinogens, cancer-cell growth, invasion and metastasis, and promote apoptosis of cancerous cells. It occurs naturally in plants either esterified with fatty acids in the cell membranes or in free form within the cells. After ingestion, it is emulsified by bile salts secreted into the small intestine to form micelles for digestion. After micelle formation, the esterified form is hydrolyzed to free phytosterols probably by cholesterol esterase and pancreatic lipase enzymes. Free phytosterols are then absorbed into enterocytes. In the enterocytes, these compounds become esterified to fatty acids by acyl-CoA cholesterol acyltransferases, and combined with cholesterol, triacylglycerol and apolipoproteins to form chylomicrons. The chylomicrons are secreted into the lymph and then transferred to the bloodstream, where they are transformed to chylomicron remnants after the uptake of triacylglycerol by cells and transported to the liver. In the liver, they may either be used for synthesis of bile salts or be incorporated into very low-density lipoproteins and be secreted into the blood, from where they are converted to low-density lipoproteins and presented to cells for uptake. In the tissues, they are incorporated into the cell membranes and have been found to be highly concentrated in the lungs, adrenal cortex, intestinal epithelia and ovaries.
|
References |
(data from https://clinicaltrials.gov, updated on 2026-05-12)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06331195 | ACTIVE_NOT_RECRUITING | Familial Hypercholesterolemia |
Hospital do Coracao |
2024-10-23 | |
| NCT06697977 | COMPLETED | NAFLD; Insulin Resistance; Metabolic Syndrome; Obesity; Diabetes; Nash; Dyslipidemias |
University of Jordan |
2023-08-15 | |
| NCT06954649 | COMPLETED | Cholesterol Lowering; LDL Level |
Centro de Edafología y Biología Aplicada del Segura |
2025-01-14 | |
| NCT06340308 | UNKNOWN | Dyslipidemias |
University of Pavia |
2023-06-07 | |
| NCT03563222 | Terminated | Malnutrition Child |
Fresenius Kabi |
2019-12-18 | Phase 4 |
| NCT02969720 | COMPLETED | Metabolic Syndrome x |
Universidad de los Andes, Chile |
2018-01-08 |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.